Maravai LifeSciences Holdings Inc
NASDAQ:MRVI

Watchlist Manager
Maravai LifeSciences Holdings Inc Logo
Maravai LifeSciences Holdings Inc
NASDAQ:MRVI
Watchlist
Price: 5.33 USD 3.9%
Market Cap: 1.3B USD
Have any thoughts about
Maravai LifeSciences Holdings Inc?
Write Note

Balance Sheet

Balance Sheet Decomposition
Maravai LifeSciences Holdings Inc

Current Assets 679.1m
Cash & Short-Term Investments 578.2m
Receivables 28.9m
Other Current Assets 72.1m
Non-Current Assets 599.1m
PP&E 164.6m
Intangibles 373.6m
Other Non-Current Assets 60.9m
Current Liabilities 63.2m
Accounts Payable 9.5m
Accrued Liabilities 36.4m
Other Current Liabilities 17.4m
Non-Current Liabilities 869.8m
Long-Term Debt 547.6m
Other Non-Current Liabilities 322.2m

Balance Sheet
Maravai LifeSciences Holdings Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
22
25
236
551
632
575
Cash
22
25
236
551
632
575
Total Receivables
16
19
51
118
147
56
Accounts Receivables
16
19
51
118
139
55
Other Receivables
0
0
0
0
8
1
Inventory
14
14
33
52
43
51
Other Current Assets
2
3
11
20
26
18
Total Current Assets
54
61
332
740
848
700
PP&E Net
43
94
101
95
117
223
PP&E Gross
43
94
101
95
117
223
Accumulated Depreciation
4
8
11
13
20
32
Intangible Assets
218
198
178
118
217
221
Goodwill
224
224
224
153
284
326
Other Long-Term Assets
1
1
436
813
818
18
Other Assets
224
224
224
153
284
326
Total Assets
540
N/A
578
+7%
1 271
+120%
1 918
+51%
2 282
+19%
1 487
-35%
Liabilities
Accounts Payable
4
8
8
8
6
11
Accrued Liabilities
11
17
29
29
51
57
Short-Term Debt
0
0
0
0
0
0
Current Portion of Long-Term Debt
3
3
6
6
5
6
Other Current Liabilities
19
3
88
50
48
14
Total Current Liabilities
36
30
131
94
110
87
Long-Term Debt
337
388
585
525
522
551
Deferred Income Tax
16
15
9
0
0
0
Minority Interest
4
3
66
230
360
373
Other Liabilities
3
1
392
755
745
59
Total Liabilities
395
N/A
436
+10%
1 182
+171%
1 603
+36%
1 737
+8%
1 071
-38%
Equity
Common Stock
183
184
3
3
3
3
Retained Earnings
38
42
1
185
405
286
Additional Paid In Capital
0
0
85
128
138
129
Other Equity
0
0
0
0
0
0
Total Equity
144
N/A
141
-2%
89
-37%
316
+256%
545
+73%
417
-24%
Total Liabilities & Equity
540
N/A
578
+7%
1 271
+120%
1 918
+51%
2 282
+19%
1 487
-35%
Shares Outstanding
Common Shares Outstanding
258
258
258
255
255
251

See Also

Discover More